RB0186 Selective inhibitors of phosphoglycerate mutase and phosphoglycerate kinase as lead compounds to treat diseases caused by trypanosomatid parasites

Project Details

StatusFinished
Effective start/end date17/12/1030/11/12

Funding

  • Non-EU other: £32,721.00